Alogliptin benzoate is a benzoate salt formed from alogliptin and benzoic acid. It is a pharmaceutical raw material used as a dipeptidyl-peptidase IV inhibitor for the management of type 2 diabetes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 850649-62-6
Alogliptin
pharmaceutical raw material
Citalopram hydrochloride
pharmaceutical raw material
Linaclotide
pharmaceutical raw material
Aripiprazole monohydrate
pharmaceutical raw material
Seladelpar
pharmaceutical raw material
2-((6-(3-Amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)benzonitrile
pharmaceutical raw material
(S)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
pharmaceutical raw material
2-({6-[(3R)-3-Aminopiperidin-1-yl]-3-(²H₃)methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile
pharmaceutical intermediate
2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile;benzoic acid
KEJICOXJTRHYAK-XFULWGLBSA-N
CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N.C1=CC=C(C=C1)C(=O)O